MoodMon - the first Polish application using AI in bipolar disorder and recurrent depressive disorders. patients...

The analysis aims to present the subjective assessment of the MoodMon mobile application by users diagnosed with BD and MDD.

Data were obtained from 95 participants based on a 12-question survey. It was a part of a large clinical study of the MoodMon system.

The reception of the MoodMon application was very similar regardless of the diagnosis. For most respondents, the application was a neutral tool (BD - 50.7%; MDD - 43.5%). Subjective satisfaction with using the application was reported by most users. The application was beneficial for 56.9% of respondents with BD and 78.3% with MDD disorders, primarily due to the ability to use modern technology to control symptoms. Most respondents did not see the need for changes to the application (BD - 70.8%; MDD - 60.9%). However, a small group suggested modifications to the form of voice sampling and the variety of questions. Nearly half of the patients with BD (48.6%) expressed a willingness to use the MoodMon application in the future, and a significantly higher percentage (73.9%) of those with MDD indicated the same.

In the subjective opinion of users, the MoodMon application is perceived as safe, useful and helpful in the treatment of affective disorders.